This identifies PRMT7 as a key regulator of PTEN, opening new avenues for developing therapeutic strategies aimed at enhancing bone regeneration and treating bone-related disorders, such as osteopenia and osteoporosis. The gene discussed is PRMT7; the disease is osteoporosis.